期刊
MOLECULAR PSYCHIATRY
卷 20, 期 3, 页码 286-288出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/mp.2014.180
关键词
-
资金
- NIH [1DP2OD007363]
- VA Merit Award [2I01CX000139]
- OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007363] Funding Source: NIH RePORTER
- Veterans Affairs [I01CX000139] Funding Source: NIH RePORTER
Blood biomarkers may provide a scientifically useful and clinically usable peripheral signal in psychiatry, as they have been doing for other fields of medicine. Jumping to premature conclusions, negative or positive, can create confusion in this field. Reproducibility is a hallmark of good science. We discuss some recent examples from this dynamic field, and show some new data in support of previously published biomarkers for suicidality (SAT1, MARCKS and SKA2). Methodological clarity and rigor in terms of biomarker discovery, validation and testing is needed. We propose a set of principles for what constitutes a good biomarker, similar in spirit to the Koch postulates used at the birth of the field of infectious diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据